Shantou Institute of Ultrasonic Instruments Co. Ltd.

Shantou Institute of Ultrasonic Instruments Co. Ltd.

SSZSE:301602
13.78
CNY
-0.20
(-1.43%)
0.24EPS
68.30P/E
6.92BMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.78
0.88
0.78
0.93
0.91
1.03
0.95
0.88
Basic EPS, GAAP
0.23
0.22
0.21
0.35
0.32
0.4
0.35
0.24
Free Cash Flow per Basic Share
0.15
0.23
0.15
0.35
0.2
0.31
0.28
- -
Dividend per Share
0.33
0.29
0.16
0.1
- -
- -
0.1
- -
Book Value per Share
1.28
1.2
1.32
1.67
1.99
2.39
3.18
3.13
Tangible Book Value per Share
1.24
1.17
1.32
1.63
1.95
2.36
3.15
3.1
Basic Weighted Avg Shares
428
364
366
363
361
364
425
435
Sales/Revenue/Turnover
336
322
284
336
327
376
406
382
Operating Margin (%)
29.44
31.56
100
33.83
33.37
37.95
38.46
33.02
Depreciation Expense
14
16
46
14
11
10
11
- -
Net Income, GAAP
101
80
77
127
115
146
149
103
Effective Tax Rate (%)
11.18
10.9
8.35
11.25
10.88
11.98
12.51
13.18
Profit Margin (%)
29.93
24.88
27.03
37.8
35.35
38.74
36.72
26.97
Working Capital
336
315
357
496
622
760
1,244
1,210
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
466
439
478
607
724
871
1,361
1,339
Return on Invested Capital (%)
- -
17.33
16.12
22.69
16.89
18.46
13.27
7.81
Return on Capital (%)
- -
17.71
16.94
23.39
17.34
18.26
13.35
7.86
Return on Common Equity (%)
- -
17.71
16.74
23.38
17.34
18.26
13.35
7.86

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
428
428
428
Market Capitalization
8,498
5,885
6,922

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,357
1,294
1,309
Cash, Cash Equivalents & STI
1,182
1,117
1,135
Accounts Receivable, Net
21
28
21
Inventories
142
134
132
Total Current Liabilities
106
93
99
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
26.36%
56.3%
Free Cash Flow
- -
23.41%
5.56%
Net Income, GAAP
- -
16.13%
2.3%
Sales/Revenue/Turnover
- -
5.35%
7.9%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
76
83
101
115
376
2025
98
85
- -
152
406
2026
66
83
81
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.07
0.09
0.08
0.12
0.4
2025
0.1
0.07
- -
0.14
0.35
2026
0.02
0.04
0.04
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
0.1
2026
- -
- -
- -
- -
- -

Company Description

CEO
De Lai Li
Full Time Employees
737
Sector
Health technology
Industry
Medical specialties
Address
Shantou China
IPO Date
Jan 22, 2025
Website
siui.com
Business
Shantou Institute of Ultrasonic Instruments Co. Ltd. is a China-based developer and manufacturer of medical imaging equipment and industrial non-destructive testing instruments. Founded in 1982 and headquartered in Shantou, Guangdong Province, China, the company researches, engineers, and markets ultrasonic diagnostic and inspection solutions for clinical healthcare, veterinary medicine, and industrial inspection applications across domestic and international markets. The company operates primarily through two business divisions: Medical Imaging Systems and Non-Destructive Testing (NDT) Equipment. Its medical product portfolio encompasses color Doppler ultrasound diagnostic systems marketed under the Apogee series; black-and-white ultrasonic diagnostic equipment; dedicated veterinary ultrasound imaging devices; and portable digital radiography (DR) X-ray systems, including the SR series, utilized in emergency medicine, radiology, and veterinary care. Its industrial NDT portfolio comprises phased-array ultrasonic flaw detectors, including the SyncScan series; conventional and portable ultrasonic flaw detectors under the Smartor series; precision ultrasonic thickness gauges; automated scanning and rail flaw detection systems; electromagnetic acoustic testing instruments; and an extensive catalog of ultrasonic transducers, phased array probes, calibration blocks, scanning crawlers, and inspection accessories. The company serves public and private hospitals, diagnostic centers, and veterinary clinics, as well as industrial clients across the aerospace, nuclear power, railway transportation, petrochemical, metallurgy, shipbuilding, and infrastructure construction sectors. In recent developments, Shantou Institute of Ultrasonic Instruments completed its initial public offering and listed its shares on the ChiNext market of the Shenzhen Stock Exchange in January 2025 under the stock code 301602. Following the listing, the company expanded its global corporate structure by establishing overseas subsidiaries, including Chaoyan Technology (Hong Kong) Co., Limited in 2025, to strengthen international sales channels and technical collaborations. Furthermore, the company has participated in industrial investment funds to accelerate research and development in high-end ultrasound transducers, automated inspection robotics, and advanced digital radiography technologies.